Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Lab Chip ; 18(13): 1844-1858, 2018 06 26.
Article in English | MEDLINE | ID: mdl-29796561

ABSTRACT

Recapitulation of the tumor microenvironment is critical for probing mechanisms involved in cancer, and for evaluating the tumor-killing potential of chemotherapeutic agents, targeted therapies and immunotherapies. Microfluidic devices have emerged as valuable tools for both mechanistic studies and for preclinical evaluation of therapeutic agents, due to their ability to precisely control drug concentrations and gradients of oxygen and other species in a scalable and potentially high throughput manner. Most existing in vitro microfluidic cancer models are comprised of cultured cancer cells embedded in a physiologically relevant matrix, collocated with vascular-like structures. However, the recent emergence of immune checkpoint inhibitors (ICI) as a powerful therapeutic modality against many cancers has created a need for preclinical in vitro models that accommodate interactions between tumors and immune cells, particularly for assessment of unprocessed tumor fragments harvested directly from patient biopsies. Here we report on a microfluidic model, termed EVIDENT (ex vivo immuno-oncology dynamic environment for tumor biopsies), that accommodates up to 12 separate tumor biopsy fragments interacting with flowing tumor-infiltrating lymphocytes (TILs) in a dynamic microenvironment. Flow control is achieved with a single pump in a simple and scalable configuration, and the entire system is constructed using low-sorption materials, addressing two principal concerns with existing microfluidic cancer models. The system sustains tumor fragments for multiple days, and permits real-time, high-resolution imaging of the interaction between autologous TILs and tumor fragments, enabling mapping of TIL-mediated tumor killing and testing of various ICI treatments versus tumor response. Custom image analytic algorithms based on machine learning reported here provide automated and quantitative assessment of experimental results. Initial studies indicate that the system is capable of quantifying temporal levels of TIL infiltration and tumor death, and that the EVIDENT model mimics the known in vivo tumor response to anti-PD-1 ICI treatment of flowing TILs relative to isotype control treatments for syngeneic mouse MC38 tumors.


Subject(s)
Microfluidic Analytical Techniques/instrumentation , Models, Biological , Tumor Microenvironment/immunology , Animals , Carcinoma, Non-Small-Cell Lung/chemistry , Carcinoma, Non-Small-Cell Lung/immunology , Cell Culture Techniques , Cell Line, Tumor , Cells, Cultured , Equipment Design , Humans , Image Processing, Computer-Assisted/methods , Lung Neoplasms/chemistry , Lung Neoplasms/immunology , Lymphocytes/cytology , Lymphocytes/metabolism , Mice , Microfluidic Analytical Techniques/methods
2.
Lab Chip ; 16(17): 3227-34, 2016 08 16.
Article in English | MEDLINE | ID: mdl-27411972

ABSTRACT

Blood oxygenators provide crucial life support for patients suffering from respiratory failure, but their use is severely limited by the complex nature of the blood circuit and by complications including bleeding and clotting. We have fabricated and tested a multilayer microfluidic blood oxygenation prototype designed to have a lower blood prime volume and improved blood circulation relative to current hollow fiber cartridge oxygenators. Here we address processes for scaling the device toward clinically relevant oxygen transfer rates while maintaining a low prime volume of blood in the device, which is required for clinical applications in cardiopulmonary support and ultimately for chronic use. Approaches for scaling the device toward clinically relevant gas transfer rates, both by expanding the active surface area of the network of blood microchannels in a planar layer and by increasing the number of microfluidic layers stacked together in a three-dimensional device are addressed. In addition to reducing prime volume and enhancing gas transfer efficiency, the geometric properties of the microchannel networks are designed to increase device safety by providing a biomimetic and physiologically realistic flow path for the blood. Safety and hemocompatibility are also influenced by blood-surface interactions within the device. In order to further enhance device safety and hemocompatibility, we have demonstrated successful coating of the blood flow pathways with human endothelial cells, in order to confer the ability of the endothelium to inhibit coagulation and thrombus formation. Blood testing results provide confirmation of fibrin clot formation in non-endothelialized devices, while negligible clot formation was documented in cell-coated devices. Gas transfer testing demonstrates that the endothelial lining does not reduce the transfer efficiency relative to acellular devices. This process of scaling the microfluidic architecture and utilizing autologous cells to line the channels and mitigate coagulation represents a promising avenue for therapy for patients suffering from a range of acute and chronic lung diseases.


Subject(s)
Biomimetic Materials/chemistry , Biomimetics/methods , Blood Gas Analysis/instrumentation , Endothelium, Vascular/metabolism , Equipment Design , Microfluidics/methods , Oxygen/metabolism , Absorption, Physiological , Biomimetics/instrumentation , Cells, Cultured , Cells, Immobilized , Dimethylpolysiloxanes/chemistry , Endothelium, Vascular/cytology , Human Umbilical Vein Endothelial Cells/cytology , Human Umbilical Vein Endothelial Cells/metabolism , Humans , Materials Testing , Microfluidics/instrumentation , Oxygen/blood , Surface Properties
3.
Can J Anaesth ; 37(6): 680-4, 1990 Sep.
Article in English | MEDLINE | ID: mdl-2208543

ABSTRACT

We describe a case of a 29-year-old parturient with a single ventricle and transposition of the great arteries who had lumbar epidural analgesia/anaesthesia with a local anaesthetic for labour, emergency Caesarean section and postoperative pain. Her outcome and that of her baby was successful. The anaesthetic techniques used in other parturients with similar congenital cardiac anomalies are reviewed.


Subject(s)
Anesthesia, Epidural , Anesthesia, Obstetrical , Cesarean Section , Heart Defects, Congenital/complications , Labor, Induced , Pregnancy Complications, Cardiovascular , Transposition of Great Vessels/complications , Adult , Analgesia, Epidural , Female , Heart Ventricles/abnormalities , Humans , Pain, Postoperative/prevention & control , Pregnancy
4.
Can J Anaesth ; 37(2): 262-4, 1990 Mar.
Article in English | MEDLINE | ID: mdl-2178791

ABSTRACT

This is a report of a 39-year-old parturient who had a haemodynamically compromising venous air embolism during a repeat Caesarean section under lumbar epidural anaesthesia. The embolism occurred immediately after surgical incision during surgery in the superficial subcutaneous tissues. The diagnosis was made using intraoperative precordial ultrasonic Doppler monitoring which allowed early and successful treatment.


Subject(s)
Cesarean Section/adverse effects , Embolism, Air/etiology , Intraoperative Complications/diagnosis , Ultrasonography , Adult , Embolism, Air/diagnosis , Female , Humans , Monitoring, Physiologic , Obstetric Labor Complications , Pregnancy
5.
Klin Wochenschr ; 66(12): 545-51, 1988 Jun 15.
Article in German | MEDLINE | ID: mdl-3419083

ABSTRACT

In a blind-study with 96 patients analysis of erythrocyte diameters permits to differentiate between renal-parenchymatous and post-renal microhaematuria in 89.9% of the cases. Erythrocytes on renal-parenchymatous microhaematuria are distinctly smaller (Average diameter 3.2 microns-5.6 microns) than those on post-renal microhaematuria (average diameter 5.4 microns-8.8 microns). In addition to the evaluation of erythrocyte morphology erythrocyte morphometry represents further possibility in diagnosis.


Subject(s)
Erythrocyte Deformability , Erythrocytes/pathology , Hematuria/pathology , Urine/cytology , Urologic Diseases/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Erythrocyte Count , Female , Humans , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...